EN | DE
Researcher in Laboratory © HIPS

Dr Markus Neuber

About

Markus Neuber studied biotechnology at the Beuth University of Applied Sciences Berlin and at the Saarland University in Saarbrücken. In October 2017, he graduated from Saarland University with a Master's thesis on "Optimization of griselimycins and mycoplanecins production through metabolic and bioprocess engineering".
Since 2018, he is a PhD student in the HIPS-department Microbial Natural Products led by Prof. Dr. Rolf Müller. His PhD project aims at the development of co-cultivation strategies for myxobacteria to access new secondary metabolites. Co-cultivation of microorganisms has been successful in isolating unknown secondary metabolites, including antibiotics, thus opening up new avenues for the production of bioactive compounds.


2024

Elucidation of unusual biosynthesis and DnaN-targeting mode of action of potent anti-tuberculosis antibiotics Mycoplanecins

Fu C, Liu Y, Walt C, Rasheed S, Bader C, Lukat P, Neuber M, Haeckl F, Blankenfeldt W, Kalinina O, Müller R (2024)

Nat Commun 15 (1)DOI: 10.1038/s41467-024-44953-5

2020

Supercritical Fluid Extraction Enhances Discovery of Secondary Metabolites from Myxobacteria

Bader C, Neuber M, Panter F, Krug D, Müller R (2020)

Analytical chemistry 92 (23): 15403-15411DOI: 10.1021/acs.analchem.0c02995